# An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical Practice

> **NCT02287597** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 90 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02287597
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-13
- **Primary completion:** 2018-03-21
- **Final completion:** 2018-03-21
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02287597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02287597, "An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical Practice". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02287597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*